ICIs are monoclonal antibodies blocking regulatory molecules expressed on T cells, such as cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death protein-1 (PD1), or non-lymphoid tissues, such as programmed cell death protein ligand 1 (PD-L1) found on tumor cells. This evidence concerns the gene PDCD1 and neoplasm.